Viewing Study NCT03053167


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-01-06 @ 7:33 PM
Study NCT ID: NCT03053167
Status: UNKNOWN
Last Update Posted: 2017-02-14
First Post: 2017-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients
Sponsor: China Medical University, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module